A Phase I Study of Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2019
At a glance
- Drugs LMP 744 (Primary)
- Indications Lymphoma; Solid tumours
- Focus Adverse reactions
- 31 Dec 2018 Status changed from recruiting to suspended as Sponsor halted accrual due to low drug supply.
- 27 Nov 2018 Planned primary completion date changed from 1 Dec 2018 to 2 Oct 2020.
- 27 Nov 2018 Planned End Date changed from 2 Oct 2019 to 2 Oct 2020.